Experiences of ‘traditional’ and ‘one-stop’ MRI-based prostate cancer diagnostic pathways in England: a qualitative study with patients and GPs
dc.contributor.author | Merriel, SWD | |
dc.contributor.author | Archer, S | |
dc.contributor.author | Forster, AS | |
dc.contributor.author | Eldred-Evans, D | |
dc.contributor.author | McGrath, J | |
dc.contributor.author | Ahmed, HU | |
dc.contributor.author | Hamilton, W | |
dc.contributor.author | Walter, FM | |
dc.date.accessioned | 2022-07-20T09:39:33Z | |
dc.date.issued | 2022-07-26 | |
dc.date.updated | 2022-07-19T19:38:52Z | |
dc.description.abstract | Objectives: This study aimed to understand and explore patient and GP experiences of ‘traditional’ and ‘onestop’ prostate cancer diagnostic pathways in England. Design: Qualitative study using semi-structured interviews, analysed using inductive thematic analysis Setting: Patients were recruited from National Health Service (NHS) Trusts in London and in Devon; GPs were recruited via National Institute for Health Research (NIHR) Clinical Research Networks. Interviews were conducted in person or via telephone. Participants: Patients who had undergone a magnetic resonance imaging (MRI) scan of the prostate as part of their diagnostic work-up for possible prostate cancer, and GPs who had referred at least one patient for possible prostate cancer in the preceding 12 months. Results: 22 patients (aged 47 – 80 years) and 10 GPs (6 female, aged 38 – 58 years) were interviewed. Patients described three key themes: cancer beliefs in relation to patient’s attitudes towards prostate cancer; communication with their GP and specialist having a significant impact on experience of the pathway; and pathway experience being influenced by appointment and test burden. GP interview themes included: the challenges of dealing with imperfect information in the current pathway; managing uncertainty in identifying patients with possible prostate cancer, and sharing this uncertainty with them, and other social, cultural and personal contextual influences. Conclusions: Patients and GPs reported a range of experiences and views of the current prostate cancer diagnostic pathways in England. Patients valued ‘one-stop’ pathways integrating prostate MRI and diagnostic consultations with specialists over the more traditional approach of several hospital appointments. GPs remain uncertain how best to identify patients needing referral for urgent prostate cancer testing due to the lack of accurate triage and risk assessment strategies. | en_GB |
dc.description.sponsorship | Cancer Research UK | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | Prostate Cancer UK | en_GB |
dc.description.sponsorship | Urology Foundation | en_GB |
dc.description.sponsorship | BMA Foundation | en_GB |
dc.description.sponsorship | Imperial Health Charity | en_GB |
dc.description.sponsorship | Sonacare Inc. | en_GB |
dc.description.sponsorship | Trod Medical and Sophiris Biocorp for trials in prostate cancer | en_GB |
dc.description.sponsorship | Royal College of Surgeons of England | en_GB |
dc.identifier.citation | Vol. 12, article e054045 | en_GB |
dc.identifier.doi | 10.1136/bmjopen-2021-054045 | |
dc.identifier.grantnumber | C8640/A23385 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/130305 | |
dc.identifier | ORCID: 0000-0003-2919-9087 (Merriel, Samuel) | |
dc.language.iso | en | en_GB |
dc.publisher | BMJ Publishing Group | en_GB |
dc.rights | © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. | |
dc.subject | Prostate cancer | en_GB |
dc.subject | diagnostic pathway | en_GB |
dc.subject | primary care | en_GB |
dc.title | Experiences of ‘traditional’ and ‘one-stop’ MRI-based prostate cancer diagnostic pathways in England: a qualitative study with patients and GPs | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2022-07-20T09:39:33Z | |
dc.identifier.issn | 2044-6055 | |
dc.description | This is the final version. Available on open access from BMJ Publishing Group via the DOI in this record | en_GB |
dc.description | Data sharing statement: All data requests should be submitted in writing to the corresponding author | en_GB |
dc.identifier.journal | BMJ Open | en_GB |
dc.relation.ispartof | BMJ Open | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2022-07-13 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2022-07-19T19:38:54Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2022-08-03T12:17:02Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.